<DOC>
	<DOCNO>NCT00646581</DOCNO>
	<brief_summary>The purpose study find small dose insulin might affect memory , ability concentrate , improve daily function patient schizophrenia schizoaffective disorder . Insulin use treat diabetes study . The investigator propose single dose , double-blinded , placebo-controlled trial intranasal insulin 40 subject schizophrenia schizoaffective disorder examine insulin 's effect cognition . The specific aim include : 1 . Examine effect single dos 40 IU intranasal insulin compare placebo cognitive functioning , include attention memory . 2 . Examine whether single dose intranasal insulin administration raise serum insulin level decrease plasma glucose level Insulin deliver air spray pump nose . The investigator compare one dose insulin ( 40 International Units ) placebo , inactive liquid .</brief_summary>
	<brief_title>Effect Single Dose Intranasal Insulin On Cognitive Function</brief_title>
	<detailed_description>Insulin signal brain associate improved cognitive function animal human study . Intranasal administration insulin , non-invasive minimizes risk hypoglycemia , may represent new intervention approach potential improve cognition real life function patient schizophrenia .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age 1865 year Diagnosis schizophrenia , subtype schizoaffective disorder , subtype Male female Stable dose current antipsychotic drug least one month Well establish compliance outpatient treatment per treat clinician 's judgement . Able complete cognitive assessment battery ( must English speaking ) Inability provide inform consent Current substance abuse On clozapine olanzapine Psychiatrically unstable per treat clinician 's judgement . Significant medical illness include uncontrolled hypertension , diabetes , seizure disorder , severe cardiovascular , cerebrovascular , pulmonary , thyroid disease etc . Incapable complete cognitive battery assessment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Memory</keyword>
	<keyword>Concentration</keyword>
	<keyword>Insulin</keyword>
</DOC>